Evogene Schedules Third Quarter 2025 Financial Results Release

Core Insights - Evogene Ltd. will release its financial results for Q3 2025 on November 20, 2025, followed by a conference call at 9:00 AM ET to discuss the results [1][2]. Company Overview - Evogene Ltd. is a pioneering company in computational chemistry, focusing on the generative design of small molecules for the pharmaceutical and agricultural sectors [3]. - The company's technology is centered around ChemPass AI, a proprietary generative AI engine that enhances the design of novel, highly potent small molecules, optimizing multiple critical parameters [3]. - This platform aims to improve success rates while reducing development time and costs [3]. Strategic Focus - Evogene is dedicated to creating breakthrough products through strategic partnerships and internal product development, emphasizing the integration of scientific innovation with real-world industry needs, termed "Real-World Innovation" [4].